AbbVie forecasts 2025 profit above estimates on newer immunology drugs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. ONON
6. RTB
7. AAPL
8. BA
9. RARE
10. ACN

Go back to AbbVie forecasts 2025 profit above estimates on newer immunology drugs
AbbVie (NYSE: ABBV) Delayed: 263.96 --0 (-0%)
Previous Close $263.96    52 Week High $68.12 
Open $263.96    52 Week Low $50.71 
Day High $263.96    P/E 57.26 
Day Low $263.96    EPS $4.61 
Volume 313